Venlafaxine XR Biotech 37,5 mg / 75 mg / 150 mg Hard prolonged-release capsules
PDF Leaflet Revision Date: 30 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and anxiety disorders.
Dosage (summary)
Initial dose: 75 mg once daily; may increase to 150 mg, up to 375 mg if needed.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- SSRIs
- SNRIs
- Lithium
Contraindications
- Hypersensitivity to venlafaxine
- Concomitant use with MAOIs
- Children under 18 years
Common side effects
- Dizziness
- Dry mouth
- Nausea
- Insomnia
- Hypertension
Counselling Points
- Take with food
- Do not crush or chew capsules
- Monitor for mood changes
Serious warnings
- Risk of suicidal thoughts
- Serotonin syndrome
- QT prolongation
Important Disclaimer
The Venlafaxine XR Biotech 37,5 mg / 75 mg / 150 mg Hard prolonged-release capsules professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
